Facebook's IPO: Thoughts On Momentum, Pricing And Valuation

New Post Public Reply Private Reply Replies (0) Message Board
Stock Buff

Facebook's IPO: Thoughts On Momentum, Pricing And Valuation (It's Still No Buy)

Guest post written by Aswath Damodaran

Aswath Damodaran is Professor of Finance at the Stern School of Business at New York University.

Aswath Damodaran

Now that the Facebook IPO is behind us, though the hype and the debate about the offering will continue for the weeks to come, it is time to step back and make an assessment of its value as a company, how it was priced and what may have gone awry.

Let’s start with this: yes, Facebook can be valued.

Facebook is a company with tremendous potential, with two key drivers of value: an immense user base and unparalleled information about these users. The question is whether they can convert this potential into profits, and if so, how quickly. In its IPO filing in February, Facebook reported 2011 pre-tax operating profits of $1.8 billion on revenues of $3.7 billion, making it, by far, the largest and most profitable of the social media companies. Here are four key value drivers for Facebook:

  • Revenue growth : Facebook has been on a steep growth path, with revenues growing 150% in 2009 and 88% in 2010, but the drop off in revenue growth from 2010 to 2011 suggests that growth will moderate. If the company can maintain a compounded revenue growth of 40% for the next 5 years, with growth rates scaling down after that towards the growth rate of the economy, the firm will have revenues of $44 billion in ten years, which would put it on the same growth path as Google in its first years as a public company.
  • Operating margins : Facebook’s current operating margin of 45.68% is mind-boggling and likely to decline as revenues get larger. If Facebook is able to maintain a pre-tax margin of 35% (close to Apple’s, and higher than Google’s) as a mature company, it would be pulling off a very difficult feat.
  • Cost of growth : As Facebook’s revenue grows, it will find itself under pressure to pay more for this growth. In fact, its acquisitions of Tagtile , Glancee and especially Instagram (for $1 billion) in the three months since the initial S-1 filing suggest that the company will be aggressive in its pursuit of growth, which is both good news (for those seeking growth) and bad news (for those worried about the cost of that growth).
  • High risk : There is significant risk in the company. In valuing the company,  we use a cost of capital of 11.42%, which would put Facebook in the top quartile of publicly traded U.S. firms in terms of risk.

These inputs yield a value of equity for Facebook of about $70 billion, and a value per share of $29. Assuming a company will grow like Google and have margins like Apple is, by definition, optimistic and this value would be at the upper end of my range. Assuming a more rocky road to scaling up and lower profitability will deliver a value in the $20-$25 range.

Some may disagree with me on my basic assumptions, either viewing them as over optimistic or over pessimistic, but I think a discussion centered on growth, profitability and the cost of growth is not only a healthy one but one that we should be having about all young, growth companies.

I would use this framework to challenge two oft-stated views about these companies: (a) that they cannot be valued today because the future is too uncertain or (b) that they must be worth very little because they don’t have significant earnings today. The first is a cop-out, since not making estimates is not going to make uncertainty go away, and the second will leave you on the sidelines with any young, growth company.

Facebook has been a quasi-public company for a couple of years now, thanks to the rise of the private share market. The company traded in this market fro months before the investment banking syndicate priced it at $38 a share last Thursday. Much as I would like to believe that the pricing of Facebook in the IPO was based upon an assessment of the fundamentals, I am a realist. Much of what passes for valuation on Wall Street and corporate boardrooms is not valuation, but pricing.

Put bluntly, the investment bankers spent the bulk of the last week surveying investors, trying to get a sense of what they would pay, rather than assessing what Facebook was worth.

In hindsight, Facebook was priced right on Friday morning, but valued wrong. That may sound odd, given what the stock has done since, but I think it indicates one of the dangers of pricing stocks. You are trying to play the momentum game, and it is one that can shift on you quickly. I am surprised that it happened so soon after the offering, but the bankers and the company not only overplayed their hands with the extended hype and the hiking up of the offering price, but were undercut by insiders cashing out in the days leading up to it. While I would love to point to the decline in the stock price since the offering as evidence that the market is cognizant of value, I think it is more the consequence of momentum investors, disappointed in their inability to make money from the promised IPO pop, heading for the exits.

While we can debate what Facebook’s value is and whether investment bankers mispriced the stock, there can be no debate on the fact that the corporate governance at the company is abysmal. From the decision to incorporate as a “controlled” corporation to issuing shares to the public with diluted voting rights, the message has been sent that this is Zuckerberg’s company and that stockholders are just capital providers. Here is why we should care: Facebook has a great product but it is not a great company, not yet. To become one, it will have to navigate challenges in scaling up growth, while maintaining profitability and controlling costs. Like all businesses, the top managers will stumble along the way, and unless challenged, will not see the need to adapt.

With its user base, Facebook has the ingredients to generate sizable profits down the road, albeit with substantial risks along the way. At the right price, I would buy the company, notwithstanding the uncertainty about the future.

At the IPO offering price or even at the price at which it is trading at right now, I would not.

http://www.forbes.com/sites/ericsavitz/2012/0...ll-no-buy/

Meta Platforms, Inc. (META) Stock Research Links

META Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midterm Election Insights: Border Enforcement Debate Heats Up

Updated Category News Views 153

The Midterm Aftermath: What Really Matters So the ballots are counted, and once again, the shiny chatter about midterms seemed to orbit more around wallet aches and foreign skirmishes than dusty border control debates. But, dig a bit deeper—like poking at a sore spot—and you'll find border security sitting patiently in the wings. Not gone, just waiting for its...

Continue Reading
Cognex Delivers Record Q3 Results, Eyes Future Growth

Updated Category News Views 107

Shaking Up the Leaderboard with Record Revenues You want a testament to a well-oiled machine? Look no further than Cognex Corporation, flaunting a record quarterly revenue hitting $313 million. That's a hearty 13% uptick from last year. Peel back the layers, and excluding a one-time boon from a partnership last year, you're staring at a 19% year-over-year surge. Talk...

Continue Reading
Breeze Airways Secures $228M for Fleet Expansion

Updated Category News Views 58

Breeze Airways and AIP's Milestone Deal Just as the ink is drying on the balance sheets, Breeze Airways is busy making significant moves in the aviation game. Partnering with AIP Capital, they just locked in a $228 million secured debt facility to grab six new Airbus A220-300 aircraft. Now, that’s how you stake your claim in the market. What we’ve got here isn’t...

Continue Reading
NIH Seeks AI Solutions for Kidney Disease Breakthroughs

Updated Category News Views 83

A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...

Continue Reading
Cooper Standard Faces Challenges Despite New Business Wins

Updated Category News Views 156

Cooper Standard's Balancing Act Alright, let’s cut straight to the chase. Cooper Standard (NYSE: CPS) finds itself dabbling in a tricky dance—juggling sparkling new business awards while grappling with stubborn inflationary headwinds and a kick to the shin from production volume shortfalls. Third quarter of 2026, and they reported net new business awards worth a hefty...

Continue Reading
Truelink's Strategic Expansion: GES Acquires CSG Creative

Updated Category News Views 31

Truelink's Big Move in Creative Marketing I don't throw around the word 'synergy' lightly, but this Truelink Capital move has me grudgingly utter it. Picture this: GES, a big dog in event marketing, just grabbed CSG Creative, a firm with its teeth sunk deep into association and event organizer marketing. It sounds like the kind of match you only find lurking in the fancy...

Continue Reading
PSG's Anna AI Wins Vizient's Innovative Tech Nod

Updated Category News Views 79

Hospital Hiring Gets a Tech Boost In the bustling world of healthcare recruitment, it's like trudging through quicksand with a time bomb strapped to your back. That's where PSG Global Solutions sauntered into the Las Vegas spotlight with Anna AI, their generative AI marvel that just snagged the Innovative Technology designation from Vizient. This ain’t your...

Continue Reading
Cogent's Q3 2026: A Mixed Bag of Financial Moves

Updated Category News Views 110

Cogent Communications' Latest Quarter Insights When you hitch your wagon to the communications and internet industry, there's no escaping the hard truths from meticulous quarterly reports. Take Cogent Communications' latest Q3 2026 results, where numbers speak louder than words. Service revenue dipped to $231.2 million for the quarter, a 1.8% drop compared to Q2. And...

Continue Reading
Fosun's Strategic Innovations Unveiled at CIIE 2026

Updated Category News Views 108

Fosun's Nine-Year CIIE Journey Fosun's been trotting out its innovations at the China International Import Expo (CIIE) for nine straight years. With 162 countries in the mix this time around, they're not just playing house—it’s downright world-class boasting. Fosun’s rolling out their hard-hitters in the medical tech space, showing they’re no rookies to the...

Continue Reading
Marini SkinSolutions Wins with Night Zyme Complex

Updated Category News Views 89

Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Trump Administration's Proposed Citizenship Test Changes

Updated Category News Views 188

The Upcoming Changes to the U.S. Citizenship Test The Trump administration is reportedly taking steps to make the citizenship test in the United States more rigorous. This potential revamp may introduce an essay requirement aimed at better assessing applicants’ understanding of U.S. civics and their commitment to American values. Possible Introduction of an Essay...

Continue Reading
Health Union Unveils ATTR-Amyloidosis.net for Patient Support

Updated Category News Views 84

Health Union Launches ATTR-Amyloidosis.net Community New Digital Health Community Delivers Rare Disease Resources and Peer Support for ATTR Amyloidosis Patients and Caregivers Health Union, renowned for its leadership in online community activation and health data, has proudly introduced ATTR-Amyloidosis.net. This innovative platform is dedicated to those affected by ATTR...

Continue Reading
SAMA Unveils A60 and A40 CPU Coolers for Gamers and Creators

Updated Category News Views 239

Introducing SAMA's Latest CPU Coolers: A60 and A40 Series SAMA, a prominent name in the performance PC hardware landscape, is excited to present its cutting-edge A60 and A40 series CPU air coolers. These new models are designed to meet the thermal demands of modern gamers, content creators, and avid PC builders while ensuring compatibility with both Intel and AMD...

Continue Reading
Borussia Dortmund's Japan Tour 2026 Hits Record Highs

Updated Category News Views 30

Eye-Opening Fan Engagement and Record-Breaking Reach Borussia Dortmund pulled out all the stops with its Japan Tour 2026, folks, setting new standards in fan engagement and media reach. More than 70,000 fans interacted directly with BVB during their stint in Japan. We're talking about face-to-face meetups at events like stadiums, training sessions, and special gatherings....

Continue Reading
Warren Buffett's Strategic Moves in Occidental Petroleum Investments

Updated Category News Views 421

Warren Buffett's Insightful Investment Strategy In the complex realm of stock trading, where numerous indicators can create confusion, one of the most straightforward approaches is to observe professional trading activity. Warren Buffett, the renowned investor behind Berkshire Hathaway Inc. (NYSE: BRKa), has recently made headlines with his continued focus on value stocks...

Continue Reading